Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore

John R. Tyson, Phillip James, David Stoddart, +14

Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults

Mark A. Brockman, Francis Mwimanzi, Hope R. Lapointe, +23

The Journal of Infectious Diseases

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

Zabrina L. Brumme, Francis Mwimanzi, Hope R. Lapointe, +40

npj Vaccines

HIV Drug Resistance Testing by High-Multiplex “Wide” Sequencing on the MiSeq Instrument

Hope R. Lapointe, Winnie Dong, G. Q. Lee, +9

Antimicrobial Agents and Chemotherapy

People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses

Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, +39

The Journal of Infectious Diseases

Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose

Francis Mwimanzi, Hope R. Lapointe, Peter K. Cheung, +27

The Journal of Infectious Diseases

COVID-19 vaccine immunogenicity in people with HIV

Cecilia T. Costiniuk, Joel Singer, Terry Lee, +27

AIDS

SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells

Eva M. Stevenson, Sandra Terry, Dennis C. Copertino, +30

Nature Communications

Weak humoral immune reactivity among residents of long-term care facilities following one dose of the BNT162b2 mRNA COVID-19 vaccine

Mark A. Brockman, Francis Mwimanzi, Yurou Sang, +17

Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy

Zabrina L. Brumme, Francis Mwimanzi, Hope R. Lapointe, +40